A pharmaceutical launch sits at the intersection of medicine, marketing, and regulation. Every word, every visual, every graphic has to clear medical, legal, and brand review , each with non-overlapping requirements. The work is translation as much as it is design.
We partnered on the digital go-to-market for a therapy considered a category-defining breakthrough, addressing one of the most pressing health concerns of the moment.
Dense clinical data, mechanism of action, efficacy, dosage logic, patient fit, became medical illustration designed for a clinician with limited time and high stakes . The campaign's spine was a streamlined digital platform serving as resource hub and launchpad, built so the next launch could reuse the architecture. Templates and visual systems were designed to clear those reviews without friction, the approval logic built into the format, so it didn't have to be re-argued asset by asset.
The work enabled clinicians to evaluate and prescribe with confidence. We became a long-term creative partner for the client and the agency teams around them. Specific data points, outcomes, and branding sit behind a non-disclosure boundary.